Brighton Jones’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-19,650
Closed -$22.4K – 1389
2026
Q2
$22.4K Buy
+19,650
New +$23.4K ﹤0.01% 1395

Other funds holding AKBA

Brighton Jones's AKBA Position: Q3 2026 in Review

Brighton Jones sold out of Akebia Therapeutics (AKBA) in Q3 2026, closing a stake of 19,650 shares — an estimated $22.4K sold.

Brighton Jones first reported a position in AKBA in Q2 2026 and held it in 1 quarter. The position peaked at $22.4K in Q2 2026. 125 funds tracked by Wall St. Rank hold AKBA as of Q3 2026.

  • Brighton Jones reported no remaining Akebia Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Brighton Jones sold 19,650 Akebia Therapeutics shares in Q3 2026, an estimated $22.4K.
  • Brighton Jones first reported a position in Akebia Therapeutics in Q2 2026 and held it in 1 quarter.
  • Brighton Jones's Akebia Therapeutics position peaked at $22.4K in Q2 2026.
  • 125 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.